ARCHIVES

Congressional Committee, SEC Probe ImClone’s Statements To Shareholders.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

New Community Control Program May Be Developed

October 24, 1975

Propac To Recommend Reclassification Of Five Leukemia/Lymphoma Diagnosis Related Groups

March 21, 1986

Also NCI appoints members of Clinical Trials Working Group to review trials system.

January 9, 2004

Funding and Direction of IL-2/LAK Trials Questioned By DCT Board

March 3, 1989

ONS Opposes AMA On “Registered Care Technologist”

August 19, 1988

“Whatever Happened To…?” ACS Follows Up Five Years Later

August 26, 1977